What Does it Mean to be in the NSMP Category of Uterine Cancer?
Stephanie Gaillard, MD PHD, Director, Gynecologic Cancer Trials and Co-Director, Developmental Therapeutics/Phase I Clinical Trials Program, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center. Dr. Gaillard will explain what the No Specific Molecular Profile (NSMP) category of endometrial/uterine cancer is and tell us about the research that is going on in the various subcategories of NSMP. The NSMP molecular category includes molecular mutations that don’t fit into the three other categories: POLE Ultramutated, MS-H, Copy number high/P53 mutated. Some of the common attributes of the NSMP category are: pMMR, MS-I Stable (aka MS-S), Copy number low, ER+ PR+, HER2-, PIK3ca, KRAS, PTEN, CTNNB1, L1CAM, or others. ▶️ Presenter: Stephanie Gaillard, MD PHD Director, Gynecologic Cancer Trials and Co-Director, Developmental Therapeutics/Phase I Clinical Trials Program, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center ▶️ Access our FREE services about uterine or endometrial cancer at: sharecancersupport.org/uterine-cancer/ ▶️ Subscribe to our newsletter: sharecancersupport.org/newsletter/ ▶️ Learn from our endometrial/uterine cancer experts in our playlist: https://bit.ly/4cc05sm ▶️ Follow us on social media: Instagram: instagram.com/sharecancersupport/ Facebook: facebook.com/SHARECancerSupport LinkedIn: linkedin.com/company/share-cancer-support/ #sharecancersupport #uterinecancer #uterinecancertreatment #cancertreatments

Report Back from SGO 2026: What’s New in Uterine Cancer?

Understanding Uterine Cancer Treatment Options

Clinical Tipping Points In Portal Hypertension Virtual Broadcast

How Cancer Actually Develops — And Why Symptoms Appear So Late

I Investigated The Country Where it's Illegal To Be Fat

Too Young for Cancer: Sydney Towle on Fighting for Her Life at 25

Understanding Low-Grade Serous Ovarian Cancer: Treatments, Trials, and What's Next

Professor Jiang: World War 3 Is About To Begin, Let Me Explain!

Golden Retriever Meets Completely Broken Rescue for the First Time

Beyond BRCA: What Else Should You Know About Genetic Testing?

May 2026 - Research Spotlight with Dr. DeMayo and Dr. Sochet

New and Emerging Treatment Options for Ovarian Cancer

Doctors Said It Was ANXIETY But It Was CANCER! - Melissa | Stomach Cancer | The Patient Story

Navigating Uterine Cancer Recurrence

SABCS 2025 Highlights: Key Clinical Trial Updates in Metastatic Breast Cancer

Stop Rambling: The 3-2-1 Speaking Trick That Makes You Sound Like A CEO

Top Medical Breakthroughs from the San Antonio Breast Cancer Symposium

The Facts About Hormone-Blocking Therapy (that no one explained)

The Silent Symptoms of Ovarian Cancer. Doctor Explains

